PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RYTM vs. TGTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


RYTMTGTX
YTD Return30.02%80.59%
1Y Return86.37%173.69%
3Y Return (Ann)65.53%4.49%
5Y Return (Ann)22.36%31.07%
Sharpe Ratio1.472.59
Sortino Ratio2.143.28
Omega Ratio1.251.41
Calmar Ratio2.491.83
Martin Ratio5.059.49
Ulcer Index16.02%19.14%
Daily Std Dev55.17%70.18%
Max Drawdown-92.10%-99.99%
Current Drawdown-11.23%-98.43%

Fundamentals


RYTMTGTX
Market Cap$3.94B$4.81B
EPS-$4.32-$0.10
Total Revenue (TTM)$112.53M$264.79M
Gross Profit (TTM)$99.35M$233.60M
EBITDA (TTM)-$259.92M$2.41M

Correlation

-0.50.00.51.00.3

The correlation between RYTM and TGTX is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

RYTM vs. TGTX - Performance Comparison

In the year-to-date period, RYTM achieves a 30.02% return, which is significantly lower than TGTX's 80.59% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%20.00%40.00%60.00%80.00%100.00%JuneJulyAugustSeptemberOctoberNovember
52.58%
77.07%
RYTM
TGTX

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RYTM vs. TGTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Rhythm Pharmaceuticals, Inc. (RYTM) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RYTM
Sharpe ratio
The chart of Sharpe ratio for RYTM, currently valued at 1.47, compared to the broader market-4.00-2.000.002.004.001.47
Sortino ratio
The chart of Sortino ratio for RYTM, currently valued at 2.14, compared to the broader market-4.00-2.000.002.004.006.002.14
Omega ratio
The chart of Omega ratio for RYTM, currently valued at 1.25, compared to the broader market0.501.001.502.001.25
Calmar ratio
The chart of Calmar ratio for RYTM, currently valued at 2.49, compared to the broader market0.002.004.006.002.49
Martin ratio
The chart of Martin ratio for RYTM, currently valued at 5.05, compared to the broader market0.0010.0020.0030.005.05
TGTX
Sharpe ratio
The chart of Sharpe ratio for TGTX, currently valued at 2.59, compared to the broader market-4.00-2.000.002.004.002.59
Sortino ratio
The chart of Sortino ratio for TGTX, currently valued at 3.28, compared to the broader market-4.00-2.000.002.004.006.003.28
Omega ratio
The chart of Omega ratio for TGTX, currently valued at 1.41, compared to the broader market0.501.001.502.001.41
Calmar ratio
The chart of Calmar ratio for TGTX, currently valued at 2.29, compared to the broader market0.002.004.006.002.29
Martin ratio
The chart of Martin ratio for TGTX, currently valued at 9.49, compared to the broader market0.0010.0020.0030.009.49

RYTM vs. TGTX - Sharpe Ratio Comparison

The current RYTM Sharpe Ratio is 1.47, which is lower than the TGTX Sharpe Ratio of 2.59. The chart below compares the historical Sharpe Ratios of RYTM and TGTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
1.47
2.59
RYTM
TGTX

Dividends

RYTM vs. TGTX - Dividend Comparison

Neither RYTM nor TGTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

RYTM vs. TGTX - Drawdown Comparison

The maximum RYTM drawdown since its inception was -92.10%, smaller than the maximum TGTX drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for RYTM and TGTX. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-11.23%
-43.82%
RYTM
TGTX

Volatility

RYTM vs. TGTX - Volatility Comparison

The current volatility for Rhythm Pharmaceuticals, Inc. (RYTM) is 18.72%, while TG Therapeutics, Inc. (TGTX) has a volatility of 26.13%. This indicates that RYTM experiences smaller price fluctuations and is considered to be less risky than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
18.72%
26.13%
RYTM
TGTX

Financials

RYTM vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between Rhythm Pharmaceuticals, Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items